Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000631214 | SCV000752228 | pathogenic | Cowden syndrome | 2021-07-13 | criteria provided, single submitter | clinical testing | This variant has been reported to be de novo in an individual affected with megalencephaly-capillary malformation syndrome (PMID: 22729224). ClinVar contains an entry for this variant (Variation ID: 217292). This variant is not present in population databases (ExAC no frequency). This sequence change replaces methionine with isoleucine at codon 1043 of the PIK3CA protein (p.Met1043Ile). The methionine residue is highly conserved and there is a small physicochemical difference between methionine and isoleucine. Experimental studies have shown that this missense change increases PIK3CA basal kinase activity and lipid binding (PMID: 15930273, 22120714). For these reasons, this variant has been classified as Pathogenic. |
Care4Rare- |
RCV000201236 | SCV003932127 | pathogenic | PIK3CA related overgrowth syndrome | criteria provided, single submitter | research | ||
Gene |
RCV003320599 | SCV004025748 | pathogenic | not provided | 2023-08-09 | criteria provided, single submitter | clinical testing | De novo variant with confirmed parentage in multiple patients with PIK3CA-related overgrowth and brain malformations spectrum disorder in the published literature (Riviere et al., 2012; Mirzaa et al., 2016) and mosaic variant in a patient with PIK3CA-related overgrowth and brain malformations spectrum disorder referred for genetic testing at GeneDx; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29883676, 26627007, 18628094, 18516290, 27631024, 33745098, 29707142, 29650325, 29453417, 22729224, 25157968, 15930273, 34693559, 22120714, 35468270, 36635288, 37456262, 36468132, Nasomyont[CaseReport], 36710374, 32398863, 35070505, 34638442, 35715244, 35359373, 35154272) |
Clinical Genomics Laboratory, |
RCV000201236 | SCV000255983 | pathogenic | PIK3CA related overgrowth syndrome | 2014-10-18 | no assertion criteria provided | clinical testing | |
Database of Curated Mutations |
RCV000442578 | SCV000504942 | likely pathogenic | Neoplasm of the large intestine | 2015-07-14 | no assertion criteria provided | literature only |